Literature DB >> 9492011

Regulation of adrenomedullin production in rat endothelial cells.

Y Isumi1, H Shoji, S Sugo, T Tochimoto, M Yoshioka, K Kangawa, H Matsuo, N Minamino.   

Abstract

Adrenomedullin (AM) is a potent vasorelaxant peptide recently identified in extracts of pheochromocytoma. We have found that AM is actively secreted from endothelial cell (EC) and vascular smooth muscle cell (VSMC). To elucidate the function of AM secreted from EC, the effects of 43 substances on secretion of AM from cultured rat EC were examined in this study. We first confirmed that synthesized AM was not stored but constitutively secreted from EC, indicating that the amount secreted could be used as an index of AM synthesis in EC. EC secreted AM at a rate 5.8 times higher than VSMC, and AM gene transcription in EC significantly contributed to the total aortic AM messenger RNA. Tumor necrosis factor, interleukin-1, and lipopolysaccharide augmented AM secretion from EC, showing cooperative effects, which suggests that AM secreted from EC participates in the induction of hypotension in septic shock. Transforming growth factor beta1 and FCS suppressed AM secretion but stimulated endothelin-1 (ET-1) secretion. Thrombin potently stimulated AM secretion from EC but suppressed it from VSMC. Thyroid hormone and phorbol ester increased AM and ET-1 secretion but to a lesser extent. Interferon-gamma inhibited AM secretion from EC, whereas oxidized LDL stimulated it. Regulation of AM production in EC is found to be similar to that of VSMC with several exceptions, but AM and ET-1 production in EC are deduced to be controlled independently and by different mechanisms. AM stimulates cAMP production in EC, though receptors expressed on cultured rat EC are not specific to AM but to calcitonin gene-related peptide. Based on these findings, AM production in EC is thought to be regulated by a variety of substances coming from blood and neighboring cells, and the secreted AM is deduced to dilate blood vessels as an endothelium-derived relaxing factor competing with ET-1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9492011     DOI: 10.1210/endo.139.3.5789

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  Role of adrenomedullin in Lyme disease.

Authors:  Meghan L Marre; Courtney T Darcy; Janeth Yinh; Shizuo Akira; Satoshi Uematsu; Allen C Steere; Linden T Hu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

Review 2.  Thyroid hormone and blood pressure regulation.

Authors:  Sara Danzi; Irwin Klein
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

3.  Modulation of plasma adrenomedullin by epinephrine infusion during head up tilt.

Authors:  Andreas Roessler; Nandu Goswami; Bernd Haditsch; Helmut Hinghofer-Szalkay
Journal:  Eur J Appl Physiol       Date:  2010-10-06       Impact factor: 3.078

4.  Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients.

Authors:  Erhan Tatar; Fatih Kircelli; Gulay Asci; Juan Jesus Carrero; Ozkan Gungor; Meltem Sezis Demirci; Suha Sureyya Ozbek; Naim Ceylan; Mehmet Ozkahya; Huseyin Toz; Ercan Ok
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

5.  Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration.

Authors:  Dan W Siemsen; Erin Dobrinen; Soo Han; Kari Chiocchi; Nicole Meissner; Steve D Swain
Journal:  Am J Pathol       Date:  2015-12-11       Impact factor: 4.307

6.  Effects of adrenomedullin gene overexpression on biological behavior of hepatic stellate cells.

Authors:  Yi Wang; Jin-Sheng Zhang; Guang-Cun Huang; Qi Cheng; Zhong-Hua Zhao
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

7.  Production of adrenomedullin from synovial cells in rheumatoid arthritis patients.

Authors:  T Matsushita; N Matsui; S Yoshiya; H Fujioka; M Kurosaka
Journal:  Rheumatol Int       Date:  2003-04-23       Impact factor: 2.631

8.  A comparative study of the ability of calcitonin gene-related peptide and adrenomedullin(13 - 52) to modulate microvascular but not thermal hyperalgesia responses.

Authors:  D Q Chu; M Choy; P Foster; T Cao; S D Brain
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

9.  Small GTPase Rap1A/B Is Required for Lymphatic Development and Adrenomedullin-Induced Stabilization of Lymphatic Endothelial Junctions.

Authors:  Wenjing Xu; Erika S Wittchen; Samantha L Hoopes; Lucia Stefanini; Keith Burridge; Kathleen M Caron
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 10.  Adrenomedullin in vascular diseases.

Authors:  Katsuyuki Ando; Tatsuo Shimosawa; Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.